IVISense Integrin Receptor 645 Fluorescent Probe (IntegriSense)
IVISense Integrin Receptor 645 Fluorescent Probe (IntegriSense)
Integrins are a superfamily of transmembrane cell surface receptors that mediate signal transduction, cell-to-cell interaction, and cell-to-extracellular matrix adhesion - key processes for healthy cells as well as progression of disease states such as atherosclerosis and cancer, where integrins contribute to angiogenesis, tumorigenesis, and metastasis.
Among this superfamily, αvβ3 integrin holds promise as a therapeutic target in areas such as immuno-oncology, where αvβ3 integrin may prevent tumors from evading the immune system. Revvity's IVISsense™ Integrin Receptor fluorescent probes (IntegriSense™) are designed to target αvβ3 integrin for monitoring tumor growth, angiogenesis and assessing treatment efficacy.
For research use only. Not for use in diagnostic procedures.
| Feature | Specification |
|---|---|
| Unit Size | 1 Vial (10 doses) |
Integrins are a superfamily of transmembrane cell surface receptors that mediate signal transduction, cell-to-cell interaction, and cell-to-extracellular matrix adhesion - key processes for healthy cells as well as progression of disease states such as atherosclerosis and cancer, where integrins contribute to angiogenesis, tumorigenesis, and metastasis.
Among this superfamily, αvβ3 integrin holds promise as a therapeutic target in areas such as immuno-oncology, where αvβ3 integrin may prevent tumors from evading the immune system. Revvity's IVISsense™ Integrin Receptor fluorescent probes (IntegriSense™) are designed to target αvβ3 integrin for monitoring tumor growth, angiogenesis and assessing treatment efficacy.
For research use only. Not for use in diagnostic procedures.
IVISense Integrin Receptor 645 Fluorescent Probe (IntegriSense)
IVISense Integrin Receptor 645 Fluorescent Probe (IntegriSense)
Product information
Overview
IVISense Integrin Receptor 645 fluorescent imaging probe for in vivo detection of αvβ3 integrin is a low molecular weight peptidomimetic antagonist coupled to a red fluorochrome. This validated, high affinity (Kd = 4.2 nM) fluorescent probe has improved circulation half-life and specificity over RDG peptide-based agents, with selectivity 5-20x for αvβ3 integrin, for precise detection of αvβ3 integrins. This integrin-targeted molecular imaging probe enables non-invasive imaging to better understand biological processes, and disease biology and progression.
Including IVISense Integrin Receptor 645 fluorescent agent in careful experimental design allows for multiplexing with other channels and/or imaging times, and can be paired with other probes to achieve maximum efficiency and flexibility in your imaging studies.
Specifications
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Targeted
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Therapeutic Area |
Angiogenesis
Atherosclerosis
Oncology/Cancer
|
| Unit Size |
1 Vial (10 doses)
|
| Wave Length |
645 nm
|
Resources
Are you looking for resources, click on the resource type to explore further.
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
SDS, COAs, Manuals and more
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
-
言語English国EU
-
言語English国United States
-
Lot numberANYLot dateSeptember 6, 2023名前
How can we help you?
We are here to answer your questions.
